News

When a patient attends physical therapy, a home exercise program is typically assigned for completion outside of the clinic. In various settings and for different diagnoses, patients may be seen at a frequency ranging from once every few weeks to three times weekly. For patients who are not seen as…

Michael, a patient I work with who has spinal muscular atrophy (SMA), sits for extended amounts of time in his wheelchair as he is unable to stand. He transfers between his wheelchair and bed during the day and stays in his bed during the afternoon and night. Over the…

Three men with late-onset spinal muscular atrophy (SMA) undergoing treatment with the approved therapy Evrysdi (risdiplam) were able to conceive with their partners, a case series reported. None of the pregnancies were planned, and…

A year of disease-modifying therapies (DMTs) improved motor function, particularly fine motor skills, in people with spinal muscular atrophy (SMA) who could sit, but not walk due to disease progression before they had…

Powered, ride-on toy cars to help children with spinal muscular atrophy (SMA) type 1 be more mobile must be adapted for easy access and match a child’s motor abilities, according to parents who took…

Most adolescents and adults with spinal muscular atrophy (SMA) have normal sensory nerve function, even those with long-lasting disease, regardless of SMA type, a study in the Netherlands shows. Nerve conduction tests had abnormal results in about…

Children living with spinal muscular atrophy (SMA) in the U.K. can switch treatments based on practical needs and preferences without experiencing unexpected disease progression, according to a study that drew on data from the SMA…

The balance of amino acids capable of influencing neurological function is disrupted in patients with spinal muscular atrophy (SMA) and in mouse models, a study found. Observed changes in patients were partially normalized after treatment with…

A tablet formulation of Evrysdi (risdiplam) for spinal muscular atrophy (SMA) recently approved in the U.S. is designed to give patients a new option, a Genentech official said. “Evrysdi is the only oral, non-invasive…

Over the past seven years, I’ve been working with a patient, Michael, who has spinal muscular atrophy (SMA), toward many different goals. If we’re being honest, we have been experimenting on how to reach those goals since there is a lot unknown around physical therapy and SMA. While…